BIOMARKER:

EGFR mutation + KRAS mutation

Entrez ID:

Related biomarkers:

‹

›

EGFR mutation + KRAS mutation EGFR mutation + KRAS mutation	Lung Non-Squamous Non-Small Cell Cancer Lung Non-Squamous Non-Small Cell Cancer	EGFR mutation + KRAS mutation EGFR mutation + KRAS mutation	Lung Non-Squamous Non-Small Cell Cancer Lung Non-Squamous Non-Small Cell Cancer	Tyrosine kinase inhibitor Sensitive: C3 – Early Trials	Tyrosine kinase inhibitor Sensitive: C3 – Early Trials
EGFR mutation + KRAS mutation EGFR mutation + KRAS mutation	Non Small Cell Lung Cancer NSCLC	EGFR mutation + KRAS mutation EGFR mutation + KRAS mutation	Non Small Cell Lung Cancer NSCLC	Tyrosine kinase inhibitor Resistant: C3 – Early Trials	Tyrosine kinase inhibitor Resistant: C3 – Early Trials
EGFR mutation + KRAS mutation EGFR mutation + KRAS mutation	Lung Adenocarcinoma LUAD	EGFR mutation + KRAS mutation EGFR mutation + KRAS mutation	Lung Adenocarcinoma LUAD	Tyrosine kinase inhibitor Resistant: C3 – Early Trials	Tyrosine kinase inhibitor Resistant: C3 – Early Trials
EGFR mutation + KRAS mutation EGFR mutation + KRAS mutation	Colorectal Cancer CRC	EGFR mutation + KRAS mutation EGFR mutation + KRAS mutation	Colorectal Cancer CRC	cetuximab Resistant: D – Preclinical	cetuximab Resistant: D – Preclinical